Structures by: Shi D.
Total: 174
3-(4-Chlorophenyl)-3,4-dihydroquinazolin-2(1H)-one
C14H11ClN2O
Acta Crystallographica Section E (2004) 60, 11 o2011-o2013
a=9.788(2)Å b=13.142(3)Å c=10.114(2)Å
α=90.00° β=111.329(4)° γ=90.00°
2-Amino-3-cyano-4-(2,4-dichlorophenyl)-8-methylpyrano[3,2-c]pyran-5(4H)-one ethanol solvate
C16H10Cl2N2O3,C2H6O
Acta Crystallographica Section E (2004) 60, 11 o1995-o1997
a=9.2879(12)Å b=10.4526(12)Å c=11.0678(10)Å
α=63.905(10)° β=75.826(14)° γ=80.288(15)°
Cis-Ethyl 5-amino-1-[4-chlorophenyl-3-(6-chloro-3-pyridylmethylamino)-5,5-dimethyl-2-oxo- 1,3,2-dioxaphosphinan-1-yl]pyrazole-4-carboxylate
C23H26Cl2N5O5P
Acta Crystallographica Section E (2005) 61, 11 o3679-o3681
a=12.4196(11)Å b=12.1995(11)Å c=17.5992(15)Å
α=90.00° β=107.198(2)° γ=90.00°
2,3a-trans-1,3a-cis-1,2-Bis(4-chlorophenyl)-1',2',3'-trihydro-3a-hydroxy- benzo[e]bicyclo[3.3]octane-3-spiro-2'-indene-1'-one acetone solvate
C32H24Cl2O2,C3H6O
Acta Crystallographica Section E (2005) 61, 8 o2709-o2711
a=10.1669(16)Å b=10.9425(16)Å c=13.6510(12)Å
α=74.001(10)° β=77.008(11)° γ=88.039(13)°
1,1'-(1,2-Ethanediyl)bis(2,3-dihydro-3-methyl-1H-imidazole-2-thione)
C10H14N4S2
Acta Crystallographica Section E (2003) 59, 3 o356-o357
a=4.6670(10)Å b=19.720(3)Å c=7.0370(10)Å
α=90.00° β=107.080(10)° γ=90.00°
2-amino-4-phenyl-5,6-dihydrobenzo[h]quinazoline
C18H15N3
Acta Crystallographica Section E (2003) 59, 4 o423-o424
a=10.902(2)Å b=6.9060(10)Å c=18.577(3)Å
α=90.00° β=94.850(10)° γ=90.00°
4,5,6,7-Tetrachloro-2-(naphthalen-1-yl)isoindole-1,3-dione acetone solvate
C18H7Cl4NO2,C3H6O
Acta Crystallographica Section E (2003) 59, 7 o1066-o1067
a=7.706(3)Å b=9.007(3)Å c=16.213(6)Å
α=94.985(6)° β=91.165(6)° γ=114.879(5)°
Ethyl 2-amino-4-(4-methylphenyl)-4H-benzo[f]chromene-3-carboxylate
C23H21NO3
Acta Crystallographica Section E (2003) 59, 9 o1263-o1264
a=9.394(2)Å b=9.3960(10)Å c=11.005(2)Å
α=94.980(10)° β=98.300(10)° γ=102.950(10)°
2,2'-[1,2-bis(4-chlorophenyl)ethane-1,2-diyl]bis(1-tetralone)
C34H28Cl2O2
Acta Crystallographica Section E (2003) 59, 9 o1376-o1378
a=10.411(2)Å b=10.9750(10)Å c=13.296(2)Å
α=103.540(10)° β=112.970(10)° γ=93.890(10)°
5,5-dimethyl-8,9-methylenedioxyl-2,3-diphenyl- 5,6-dihydroimidazo[1,2-c]quinazoline
C24H21N3
Acta Crystallographica Section E (2004) 60, 1 o9-o11
a=8.1400(10)Å b=18.522(2)Å c=12.963(2)Å
α=90.00° β=94.320(10)° γ=90.00°
3,3,7-trimethyl-9-(5,5-dimethyl-3-hydroxy-2-cyclohexene- 1-one-2-yl)-1-oxo-1,2,3,4,9,10-hexahydroxanthene
C24H28O4
Acta Crystallographica Section E (2004) 60, 8 o1439-o1441
a=15.559(3)Å b=11.1768(19)Å c=23.057(4)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-4-(4-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile N,N-dimethylformamide solvate
C20H14N2O4,C3H7NO
Acta Crystallographica Section E (2004) 60, 12 o2359-o2361
a=12.472(3)Å b=13.003(3)Å c=13.620(3)Å
α=99.799(4)° β=95.399(4)° γ=104.785(5)°
Ethyl 2-amino-4-(4-methoxyphenyl)-7-methyl-5-oxopyrano[3,2-c]pyran-3-carboxylate
C19H19NO6
Acta Crystallographica Section E (2004) 60, 12 o2362-o2364
a=10.720(4)Å b=8.934(3)Å c=18.167(6)Å
α=90.00° β=94.636(7)° γ=90.00°
2-Amino-7-methyl-4-(3,4-methylenedioxyphenyl)-5-oxopyrano[3,2-c]pyran-3- carbonitrile N,N-dimethylformamide solvate
C17H12N2O5,C3H7NO
Acta Crystallographica Section E (2004) 60, 12 o2371-o2373
a=6.7513(18)Å b=11.010(3)Å c=13.740(4)Å
α=107.117(5)° β=93.142(3)° γ=104.813(5)°
2-Amino-4-(3,4-dichlorophenyl)-4H-pyrano[3,2-c]coumarin-3-carbonitrile N,N-dimethylformamide solvate
C19H10Cl2N2O3,C3H7NO
Acta Crystallographica Section E (2004) 60, 12 o2339-o2341
a=28.126(6)Å b=7.8824(13)Å c=22.096(5)Å
α=90.00° β=122.493(3)° γ=90.00°
7-Chloro-2,2-dimethyl-3-(4-methylphenyl)-1,2-dihydroquinazolin-4(3H)-one
C17H17ClN2O
Acta Crystallographica Section E (2004) 60, 12 o2495-o2497
a=6.8860(10)Å b=10.017(2)Å c=11.272(2)Å
α=89.258(9)° β=84.168(8)° γ=85.447(8)°
3-Amino-1-(3,4-methylenedioxyphenyl)-9-methoxy-5,6-dihydro-1H- benzo[f]chromene-2-carbonitrile
C22H18N2O4
Acta Crystallographica Section E (2005) 61, 1 o84-o86
a=10.2770(10)Å b=6.9852(5)Å c=25.695(3)Å
α=90.00° β=92.512(9)° γ=90.00°
Methyl 2-amino-4-(4-chlorophenyl)-4H-pyrano[3,2-c]coumarin-3-carboxylate N,N-dimethylformamide solvate
C20H14ClNO5,C3H7NO
Acta Crystallographica Section E (2005) 61, 1 o87-o89
a=7.5757(5)Å b=12.7812(4)Å c=12.9142(8)Å
α=62.186(5)° β=89.802(8)° γ=74.080(6)°
Ethyl 6-amino-5-cyano-2-methyl-4-phenyl-4H-pyran-3-carboxylate
C16H16N2O3
Acta Crystallographica Section E (2005) 61, 4 o1115-o1117
a=8.1402(16)Å b=9.3393(19)Å c=11.206(2)Å
α=107.047(3)° β=103.066(4)° γ=106.257(3)°
Methyl 3-amino-1-(2-chlorophenyl)-9-methoxy-5,6-dihydro-1H- naphtha[2,1-b]pyran-2-carboxylate
C22H20ClNO4
Acta Crystallographica Section E (2005) 61, 4 o923-o925
a=8.0430(10)Å b=11.8770(10)Å c=20.233(3)Å
α=90.00° β=99.400(10)° γ=90.00°
Ethyl 5-amino-1-(4-chlorophenyl-5,5-dimethyl-2-oxo-1,3,2-dioxaphosphinan-2-yl)- 3-(6-chloro-3-pyridylmethylamino)-1H-pyrazole-4-carboxylate
C23H26Cl2N5O5P
Acta Crystallographica Section E (2005) 61, 10 o3307-o3309
a=8.1968(11)Å b=10.2180(14)Å c=16.581(2)Å
α=86.447(2)° β=85.668(3)° γ=70.083(2)°
1,3-trans-1,4-cis-1,2-Bis(2,4-dichlorophenyl)-1,2,3,3a,8,8a- hexahydrobenzo[e]pentalene-3-spiro-2'-indan-3a,1'-diol acetone solvate
C32H24Cl4O2,C3H6O
Acta Crystallographica Section E (2005) 61, 10 o3219-o3221
a=31.620(8)Å b=10.443(3)Å c=20.993(5)Å
α=90.00° β=116.931(4)° γ=90.00°
2-Amino-4-(2-chlorophenyl)-7,7-dimethyl-1-(4-methylphenyl)-5-oxo- 1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile
C25H24ClN3O
Acta Crystallographica Section E (2006) 62, 3 o1184-o1186
a=19.541(2)Å b=9.0199(8)Å c=14.8424(16)Å
α=90.00° β=124.628(2)° γ=90.00°
9-(3,4-Dichlorophenyl)-3,3,6,6-tetramethyl-1,2,3,4,5,6,7,8,9,10- decahydroacridine-1,8-dione
C23H25Cl2NO2
Acta Crystallographica Section E (2006) 62, 4 o1326-o1327
a=14.155(3)Å b=14.352(3)Å c=10.704(3)Å
α=90.00° β=90.00° γ=90.00°
O,O-Diethyl [({1-[(2-chlorothiazol-5-yl)methyl]-5-methyl-1H-1,2,3-triazol-4- yl}carbonyloxy)phenylmethyl]phosphonate
C19H22ClN4O5PS
Acta Crystallographica Section E (2007) 63, 1 o158-o160
a=8.7691(12)Å b=9.3196(13)Å c=14.389(2)Å
α=97.715(2)° β=94.826(2)° γ=92.492(2)°
O,O-Diethyl ({1-[(6-chloropyridin-3-yl)methyl]-5-methyl-1H-1,2,3-triazol-4- ylcarbonyloxy}(phenyl)methyl)phosphonate
C21H24ClN4O5P
Acta Crystallographica Section E (2007) 63, 1 o172-o174
a=8.5297(8)Å b=9.6214(9)Å c=14.6389(14)Å
α=95.865(2)° β=92.955(2)° γ=90.536(2)°
3-(6-Chloropyridin-3-ylmethyl)-7-imino-6-isobutyl-6,7-dihydro-3H-1,2,3- triazolo[4,5-d]pyrimidine
C14H16ClN7
Acta Crystallographica Section E (2007) 63, 1 o337-o339
a=14.3695(18)Å b=13.1510(17)Å c=8.3524(11)Å
α=90.00° β=93.392(2)° γ=90.00°
1-{6-(4-Chlorophenyl)-1-[(6-chloropyridin-3-yl)methyl]- 2-[(6-chloropyridin-3-yl)methylsulfanyl]-4-methyl-1,6-dihydropyrimidin- 5-yl}ethanone
C25H21Cl3N4OS
Acta Crystallographica Section E (2007) 63, 5 o2506-o2507
a=10.2887(11)Å b=11.1487(12)Å c=12.6386(13)Å
α=104.740(2)° β=95.725(2)° γ=116.332(2)°
Benzaldehyde O-[(E)-(6-chloropyridin-3-yl)methyl]oxime
C13H11ClN2O
Acta Crystallographica Section E (2007) 63, 7 o3311-o3311
a=7.6265(7)Å b=6.1724(6)Å c=26.559(3)Å
α=90.00° β=95.571(2)° γ=90.00°
1-[(6-Chloropyridin-3-yl)methyl]-3-phenylimidazolidine-2,4-dione
C15H12ClN3O2
Acta Crystallographica Section E (2007) 63, 8 o3506-o3506
a=7.7106(10)Å b=6.3329(9)Å c=28.673(4)Å
α=90.00° β=91.552(2)° γ=90.00°
1-{1-[(2-Chlorothiazol-5-yl)methyl]-2-[(2-chlorothiazol-5-yl)methylsulfanyl]- 4-methyl-6-phenyl-1,6-dihydropyrimidin-5-yl}ethanone
C21H18Cl2N4OS3
Acta Crystallographica Section E (2007) 63, 8 o3516-o3516
a=10.6123(5)Å b=18.7414(6)Å c=12.4631(9)Å
α=90.00° β=113.8200(10)° γ=90.00°
2-Methyl-2-phenyl-1,2-dihydroquinazolin-4(3H)-one
C15H14N2O
Acta Crystallographica Section E (2008) 64, 2 o450-o450
a=8.4891(7)Å b=8.7741(8)Å c=16.1351(16)Å
α=90.00° β=93.543(7)° γ=90.00°
1-Phenyl-6,7,8,9-hexahydro-1H,5H-cyclohepta[1',2':2,3]pyrido[6,5-c]pyrazol- 4-amine
C17H18N4
Acta Crystallographica Section E (2008) 64, 6 o1056
a=13.694(13)Å b=6.888(6)Å c=16.929(16)Å
α=90.00° β=112.417(12)° γ=90.00°
3-(6-Chloropyridin-3-ylmethyl)-6-propyl-6,7-dihydro-3<i>H</i>-1,2,3- triazolo[4,5-<i>d</i>]pyrimidin-7-imine
C13H14ClN7
Acta Crystallographica Section E (2006) 62, 11 o4780-o4782
a=7.1644(9)Å b=13.1572(16)Å c=15.6765(19)Å
α=91.008(2)° β=99.321(2)° γ=96.281(2)°
2,2-tetramethylene-1,2-dihydroquinazolin-4(3H)-one
C12H14N2O
Acta Crystallographica Section E (2008) 64, 2 o449-o449
a=10.3872(12)Å b=12.0252(13)Å c=16.3027(19)Å
α=90.00° β=90.00° γ=90.00°
(S)-2-(3-Nitrophenyl)-1,2-dihydroquinazolin-4(3H)-one
C14H11N3O3
Acta Crystallographica Section E (2008) 64, 2 o448-o448
a=10.9766(13)Å b=9.8626(9)Å c=11.7636(14)Å
α=90.00° β=109.697(7)° γ=90.00°
1-[(2-Chlorothiazol-5-yl)methyl]-N'-[2-(2,4-dichlorophenoxy)acetyl]- 5-methyl-1H-1,2,3-triazole-4-carbohydrazide
C16H13Cl3N6O3S
Acta Crystallographica Section E (2007) 63, 2 o953-o954
a=13.7699(13)Å b=15.1323(15)Å c=10.3635(17)Å
α=90.00° β=112.1050(10)° γ=90.00°
2,2'-(p-Phenylenedimethylenedithio)bis(4,5-dihydro-1,3-thiazine)
C16H20N2S4
Acta Crystallographica Section E (2006) 62, 9 o3949-o3950
a=14.280(3)Å b=5.1581(13)Å c=12.250(3)Å
α=90° β=103.782(4)° γ=90°
3-[(2-Chlorothiazol-5-yl)methyl]-5-(isobutylamino)-6-phenyl-3H- 1,2,3-triazolo[4,5-d]pyrimidin-7(6H)-one
C18H18ClN7OS
Acta Crystallographica Section E (2007) 63, 6 o2843-o2843
a=20.0916(18)Å b=7.2538(7)Å c=28.046(2)Å
α=90.00° β=101.527(2)° γ=90.00°
7-Amino-1,3-dimethyl-5-(4-nitrophenyl)-2,4-dioxo-1,2,3,4- tetrahydropyrido[2,3-<i>d</i>]pyrimidine-6-carbonitrile
C16H12N6O4
Acta Crystallographica Section E (2007) 63, 5 o2667-o2667
a=9.6209(9)Å b=11.7064(12)Å c=14.5493(16)Å
α=90.00° β=106.939(3)° γ=90.00°
(E)-N^2^{3-[(6-Chloropyridin-3-yl)methyl]-5-cyano-3H-1,2,3-triazol-4-yl}- N^1^,N^1^-bis(2-hydroxyethyl)formamidine
C14H16ClN7O2
Acta Crystallographica Section E (2006) 62, 12 o5464-o5466
a=7.6293(9)Å b=8.1921(9)Å c=26.351(3)Å
α=90.00° β=90.438(2)° γ=90.00°
1,3-Bis(1-phenyl-1H-tetrazole-5-ylsulfanyl)propane
C17H16N8S2
Acta Crystallographica Section E (2007) 63, 1 o110-o111
a=16.774(3)Å b=6.5029(13)Å c=18.691(4)Å
α=90.00° β=112.24(3)° γ=90.00°
O-1-((E)-1-{1-[(6-Chloropyridin-3-yl)methyl]-5-methyl- 1H-1,2,3-triazol-4-yl}ethyleneamino) O-ethyl O-phenyl phosphorothioate
C19H21ClN5O3PS
Acta Crystallographica Section E (2006) 62, 10 o4541-o4542
a=8.5491(11)Å b=10.7464(14)Å c=13.8045(17)Å
α=89.373(2)° β=76.631(2)° γ=68.565(2)°
2-[(2-Chlorophenyl)(1,2,3,4-tetrahydro-1-oxo-2-naphthyl)methyl]malononitrile
C20H15ClN2O
Acta Crystallographica Section E (2007) 63, 5 o2082-o2083
a=8.2263(8)Å b=19.3791(19)Å c=10.6624(10)Å
α=90.00° β=94.198(3)° γ=90.00°
Diethyl {2-[(4-chlorophenoxy)methyl]-9-(methylsulfanyl)-7H-pyrazolo[4,3- d][1,2,4]triazolo[1,5-d]pyrimidin-7-yl}(phenyl)methylphosphonate
C25H26ClN6O4PS
Acta Crystallographica Section E (2007) 63, 8 o3613-o3613
a=13.8732(12)Å b=13.5760(11)Å c=16.2034(14)Å
α=90.00° β=113.515(2)° γ=90.00°
8,8-Dimethyl-5-(4-methylphenyl)-8,9-dihydropyrimido[4,5-b]quinoline- 2,4,6(1H,3H,7H)-trione N,N-dimethylformamide solvate
C20H19N3O3,C3H7NO
Acta Crystallographica Section E (2008) 64, 3 o606
a=8.8252(16)Å b=10.289(2)Å c=12.316(2)Å
α=95.898(3)° β=93.115(3)° γ=94.719(3)°
4,5,9,10-Tetrahydro-4-methyl-2-phenyl-9,10-epoxy- 3H,10aH-cyclobuta[a]benzo[2,3,4-de]isoquinoline-3,5-dione
C21H15NO3
Acta Crystallographica Section C (2003) 59, 1 o36-o37
a=14.801(3)Å b=8.306(2)Å c=14.441(2)Å
α=90° β=114.150(10)° γ=90°
2,2'-(1,2-Ethanediyldithio)bis(1,3-benzothiazole)
C16H12N2S4
Acta Crystallographica Section C (2003) 59, 4 o219-o220
a=11.513(2)Å b=10.711(2)Å c=13.998(2)Å
α=90° β=114.100(10)° γ=90°
Cyclohexanespiro-2'-[2',3',6',7'-tetrahydro-1'<i>H</i>- cyclopenta[<i>d</i>]pyrimidin]-4'(5'<i>H</i>)-one
C12H18N2O
Acta Crystallographica Section E (2009) 65, 3 o615
a=10.294(2)Å b=10.461(2)Å c=10.659(2)Å
α=90.00° β=112.70(3)° γ=90.00°
6'-Methyl-1',2',3',4'-tetrahydrospirocyclohexane-2'-quinazolin-4'-one
C14H18N2O
Acta Crystallographica Section E (2009) 65, 5 o1097
a=9.4077(19)Å b=11.853(2)Å c=11.067(2)Å
α=90.00° β=106.44(3)° γ=90.00°
(<i>E</i>)-<i>N</i>'-(2-Cyanophenyl)-<i>N</i>,<i>N</i>-dimethylformamidine
C10H11N3
Acta Crystallographica Section E (2009) 65, 6 o1306
a=7.7468(15)Å b=11.212(2)Å c=11.042(2)Å
α=90.00° β=109.67(3)° γ=90.00°
2,2,7-Trimethyl-2,3-dihydroquinazolin-4(1<i>H</i>)-one
C11H14N2O
Acta Crystallographica Section E (2009) 65, 6 o1345
a=19.538(4)Å b=10.104(2)Å c=20.735(4)Å
α=90.00° β=90.00° γ=90.00°
Spiro[cyclopentane-1,2'(1'<i>H</i>)-pyrido[2,3-<i>d</i>]pyrimidin]- 4'(3'<i>H</i>)-one
C11H13N3O
Acta Crystallographica Section E (2010) 66, 9 o2301
a=10.4000(10)Å b=12.1650(15)Å c=15.370(2)Å
α=90.00° β=90.00° γ=90.00°
5'-Methyl-4'-oxo-7'-phenyl-3',4'-dihydro-1'<i>H</i>-spiro[cyclohexane-1,2'- quinazoline]-8'-carbonitrile
C21H21N3O
Acta Crystallographica Section E (2011) 67, 7 o1672
a=7.1824(15)Å b=11.233(3)Å c=11.430(3)Å
α=101.858(8)° β=93.794(9)° γ=104.606(9)°
5'-Methylsulfanyl-4'-oxo-7'-phenyl-3',4'-dihydro-1'<i>H</i>- spiro[cyclohexane-1,2'-quinazoline]-8'-carbonitrile dimethylformamide monosolvate
C21H21N3OS,C3H7NO
Acta Crystallographica Section E (2011) 67, 8 o2016
a=9.415(3)Å b=10.615(3)Å c=12.037(3)Å
α=95.092(3)° β=98.156(4)° γ=109.833(3)°
6'-Bromo-1'<i>H</i>-spiro[cyclohexane-1,2'-pyrido[2,3- <i>d</i>]pyrimidin]-4'(3'<i>H</i>)-one
C12H14BrN3O
Acta Crystallographica Section E (2012) 68, 1 o178
a=10.591(3)Å b=12.359(3)Å c=9.116(3)Å
α=90.00° β=97.951(4)° γ=90.00°
7'-Amino-1'<i>H</i>-spiro[cycloheptane-1,2'-pyrimido[4,5-<i>d</i>]pyrimidin]- 4'(3'<i>H</i>)-one
C12H17N5O
Acta Crystallographica Section E (2012) 68, 8 o2546
a=10.798(3)Å b=10.365(3)Å c=11.341(3)Å
α=90.00° β=110.287(4)° γ=90.00°
9-ethyl-13-hydroxy-14-methyl-2-(3,4,5-trimethoxy-6-methyltetrahydro-2<i>H</i>- pyran-2-yloxy)-3,3a,5b,6,9,10,11,12,13,14,16a,16b-dodecahydro-1<i>H</i>- <i>as</i>-indaceno[3,2-<i>d</i>][1]oxacyclododecine-7,15(2<i>H</i>,5a<i>H</i>)- dione
C33H50O9
Acta Crystallographica Section E (2012) 68, 8 o2488
a=8.7776(15)Å b=8.7959(15)Å c=41.737(7)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(2-Methyl-3-oxo-1,3-diphenylpropyl)acetamide
C18H19NO2
Acta Crystallographica Section E (2013) 69, 5 o633
a=9.156(5)Å b=17.668(8)Å c=10.103(5)Å
α=90.00° β=107.914(7)° γ=90.00°
C45H29N4O15Zn
C45H29N4O15Zn
Journal of the American Chemical Society (2016) 138, 12 3958-3961
a=11.7654(4)Å b=10.6457(4)Å c=29.5927(10)Å
α=90.00° β=97.818(2)° γ=90.00°
C10H15NO3S
C10H15NO3S
Journal of the American Chemical Society (2019) 141, 12 4928-4935
a=9.491(2)Å b=6.1160(8)Å c=9.9296(18)Å
α=90° β=101.54(2)° γ=90°
Co6Cs3Ge3H90K3O159W33
Co6Cs3Ge3H90K3O159W33
Crystal Growth & Design (2011) 11, 5 1913
a=13.371(3)Å b=33.458(8)Å c=36.582(9)Å
α=90.00° β=95.539(4)° γ=90.00°
H72K18Mn9O156Si4W34
H72K18Mn9O156Si4W34
Crystal Growth & Design (2011) 11, 5 1913
a=12.722(11)Å b=17.742(16)Å c=20.620(19)Å
α=91.844(15)° β=107.857(15)° γ=108.924(15)°
Ag3Ce4H60O108W22
Ag3Ce4H60O108W22
Crystal Growth & Design (2008) 8, 12 4476
a=12.3396(4)Å b=13.2484(4)Å c=18.1100(6)Å
α=94.6920(10)° β=91.8810(10)° γ=105.3390(10)°
C28H175Cu7Ge4N28Na3O192W46Y4
C28H175Cu7Ge4N28Na3O192W46Y4
Crystal Growth & Design (2013) 13, 10 4368
a=21.675(2)Å b=23.348(2)Å c=24.687(2)Å
α=93.355(2)° β=100.387(2)° γ=97.351(2)°
C28H179Cu7Gd4Ge4N28Na3O194W46
C28H179Cu7Gd4Ge4N28Na3O194W46
Crystal Growth & Design (2013) 13, 10 4368
a=21.635(2)Å b=23.415(3)Å c=24.754(3)Å
α=93.327(2)° β=100.308(2)° γ=97.322(2)°
C20H120Cu8Ge2N20O101Tb2W22
C20H120Cu8Ge2N20O101Tb2W22
Dalton transactions (Cambridge, England : 2003) (2012) 41, 35 10740-10751
a=13.771(9)Å b=23.905(16)Å c=18.536(13)Å
α=90.00° β=92.870(13)° γ=90.00°
C17H18N4O3
C17H18N4O3
RSC Adv. (2014)
a=7.9219(8)Å b=10.2365(13)Å c=11.9557(14)Å
α=108.694(2)° β=105.2940(10)° γ=100.3700(10)°
Ethyl 9-amino-7-(4-methoxyphenyl)-7H-pyrano[3,2-c]coumarin-8-carboxylate
C22H19NO6
Acta Crystallographica Section E (2004) 60, 8 o1401-o1402
a=7.6490(10)Å b=9.3320(10)Å c=14.725(2)Å
α=74.340(10)° β=75.770(10)° γ=71.160(10)°
6-chloro-3-(4-methylphenyl)-3,4-dihydroquinazolin-2(1H)-one
C15H13ClN2O
Acta Crystallographica Section E (2004) 60, 8 o1429-o1430
a=19.006(6)Å b=12.836(3)Å c=11.484(4)Å
α=90.00° β=107.764(7)° γ=90.00°
C13H13NO3S
C13H13NO3S
Journal of the American Chemical Society (2019) 141, 12 4928-4935
a=8.74710(10)Å b=8.74710(10)Å c=32.7688(14)Å
α=90° β=90° γ=90°
Cd6H56K8O96Si2W18
Cd6H56K8O96Si2W18
Crystal Growth & Design (2011) 11, 5 1913
a=23.838(8)Å b=12.084(4)Å c=30.450(10)Å
α=90.00° β=96.985(5)° γ=90.00°
C47H43CuN3O8
C47H43CuN3O8
Inorganic Chemistry (2012) 51, 6498-6506
a=18.023(4)Å b=18.952(4)Å c=12.389(3)Å
α=90.00° β=90.84(3)° γ=90.00°
C45H39N3O9Zn2
C45H39N3O9Zn2
Inorganic Chemistry (2012) 51, 6498-6506
a=11.980(2)Å b=18.625(4)Å c=17.982(4)Å
α=90.00° β=90.00° γ=90.00°